Get started
Author

Stefan Peinert

Observed names: S Peinert, S. Peinert
OpenAlex ID: A5089085879
Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
2013 · David S. Ritchie, Paul J. Neeson, et al. · Molecular Therapy · 443
PDF
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
2010 · S Peinert, H M Prince, et al. · Gene Therapy · 115
The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
2009 · Jennifer A. Westwood, William K. Murray, et al. · Journal of Immunotherapy · 74
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
2010 · P Neeson, A Shin, et al. · Gene Therapy · 45
High Response Rates with the Combination of Bortezomib, Dexamethasone and the Pan-Histone Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma in a Phase I/II Clinical Trial
2008 · Simon James Harrison, Hang Quach, et al. · Blood · 33
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Present and Future Role in Gastrointestinal Cancer Treatment: A Review
2006 · Dirk Arnold, Stefan Peinert, et al. · The Oncologist · 32
Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice
2002 · Alexander Carpinteiro, Stefan Peinert, et al. · International Journal of Cancer · 29
PDF
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice
2008 · J A Westwood, W K Murray, et al. · Gene Therapy · 23
Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
2010 · P A Thompson, H M Prince, et al. · Bone Marrow Transplantation · 21
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia
2010 · Stefan Peinert, Constantine S. Tam, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 17
Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.
2007 · Miles Prince, Hang Quach, et al. · Blood · 17
Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer
2010 · Stefan Peinert, Wilfried Grothe, et al. · Therapeutic Advances in Medical Oncology · 14
Cetuximab with oxaliplatin and capecitabine (CAPOX)in patients with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy
2005 · W. Grothe, D. Arnold, et al. · Journal of Clinical Oncology · 11
Chimeric T Cells for Adoptive Immunotherapy of Cancer: Using What Have We Learned to Plan for the Future
2009 · Stefan Peinert, Michael H Kershaw, et al. · Immunotherapy · 9
Fludarabine combinations for patients with advanced marginal zone lymphomas – best treatment option or too toxic?
2009 · Stefan Peinert, Dennis Carney, et al. · British Journal of Haematology · 6
PDF
Indolent Lymphomas Other than Follicular and Marginal Zone Lymphomas
2008 · Stefan Peinert, John F. Seymour · Hematology/Oncology Clinics of North America · 5
Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype
2008 · Stefan Peinert, David S. Ritchie, et al. · Blood · 3
Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
2005 · A. Harba, S. Peinert, et al. · Journal of Clinical Oncology · 3
Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureas
2000 · C Baum, S Peinert, et al. · Bone Marrow Transplantation · 3
The role of peri-operative treatment in resectable liver metastases of colorectal cancer
2010 · Alexander Stein, Joern Rüssel, et al. · Therapeutic Advances in Medical Oncology · 2
Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma
2009 · Stefan Peinert, Sarah Kamel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
Rapid Infusion of Rituximab Is Well Tolerated and Enables More Efficient Use of Haematology Day Ward Resources
2009 · Stefan Peinert, Margaret F. Moloney, et al. · 2
The development of novel immunotherapeutic approaches in multiple myeloma
2008 · Stefan Peinert, H. Miles Prince, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
BECAM: A salvage protocol with bevacizumab, capecitabin, and mitomycin C for patients with refractory metastatic colorectal cancer (CRC) or gastric cancer (GC)
2006 · S. Peinert, D. Arnold, et al. · Journal of Clinical Oncology · 2
Fludarabine Based Combination Therapy Is Highly Active as Primary or Salvage Treatment in Patients With Waldenstrom Macroglobulinemia
2009 · Stefan Peinert, Constantine S. Tam, et al. · 1
Works count: 40
Citation count: 916
H-index: 12
I10-index: 13
Year
Topic
Type